Mr. Kazimi founded Cumberland Pharmaceuticals Inc. and has served as the Chairman of the Board of Directors and Chief Executive Officer since the company’s inception. His career includes over 30 years in the biopharmaceutical industry. Under his leadership, Cumberland was twice named to the Inc. 500 group of fastest growing private companies in the U.S. and is now one of the largest biopharmaceutical companies headquartered in the mid-south region of the country. He was responsible for Cumberland’s initial public offering and listing on the NASDAQ stock exchange. He also serves as Chairman and Chief Executive of Cumberland Emerging Technologies Inc., a joint initiative formed among Cumberland, Vanderbilt University and the state of Tennessee.
Mr. Kazimi started his career at Brown-Forman Corporation in a series of management positions at their Jack Daniel and international divisions. He was a founding board member of Aegis Sciences Corporation, a federally certified forensic toxicology laboratory, serving through its successful sale to a private equity investment group. He serves on the Board of Directors for the Tennessee Historical Society and the Gettysburg Foundation - which partners with the National Park Service to preserve the historic Civil War Military Park. Mr. Kazimi is a member of the Board of Visitors at the Vanderbilt University School of Business and the Visiting Committee at the Loyola University New Orleans’s College of Business. He holds a B.S. from the University of Notre Dame and an M.B.A. from the Vanderbilt University Owen Graduate School of Management.
B.S., University of Notre Dame
MBA, Vanderbilt University